Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Rigel ( (RIGL) ) is now available.
Dr. Brian Kotzin has decided to step down from his role as an independent director on Rigel Pharmaceuticals’ Board of Directors, as well as from all board committees he serves on, effective September 16, 2024. His resignation is amicable and not due to any disputes concerning Rigel’s operational, policy, or practice matters.
Find detailed analytics on RIGL stock on TipRanks’ Stock Analysis page.